LakeShore Biopharma Quote - LSB

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.5468

Bid

0.4868

Ask

0.8319

Volume

0.00 Day's Range 0.00

0.50 52 Week Range 1.12

Market Cap

50.884M

Previous Close

0.5468

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

50,889

Shares Outstanding

93,058,200

Dividend Yield

PE Ratio

-0.03

Earnings Per Share (EPS)

-3.05

Revenue

687.2M

Net Profit

-283.47M

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is als... YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminum-free lyophilized rabies vaccine that was launched in China. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.yishengbio.com.

Headquarters

Beijing, Chn

Founded

1970

LakeShore Biopharma Company Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LSB. The last closing price for LakeShore Biopharma was US$0.55. Over the last year, LakeShore Biopharma shares have traded in a share price range of US$ 0.50 to US$ 1.12.

LakeShore Biopharma currently has 93,058,200 shares outstanding. The market capitalization of LakeShore Biopharma is US$50.88 million. LakeShore Biopharma has a price to earnings ratio (PE ratio) of -0.03.

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition

LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition PR Newswire GAITHERSBURG, Md., July 5, 2024 GAITHERSBURG, Md., July 5, 2024...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0832	-13.2063492063	0.63	0.672	0.5	16663	0.57226583	CS
4	-0.2032	-27.0933333333	0.75	0.7598	0.5	29184	0.63664265	CS
12	-0.5432	-49.8348623853	1.09	1.12	0.5	50889	0.79653889	CS
26	-0.5432	-49.8348623853	1.09	1.12	0.5	50889	0.79653889	CS
52	-0.5432	-49.8348623853	1.09	1.12	0.5	50889	0.79653889	CS
156	-0.5432	-49.8348623853	1.09	1.12	0.5	50889	0.79653889	CS
260	-0.5432	-49.8348623853	1.09	1.12	0.5	50889	0.79653889	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0
134AUPraise Inc	0.00 (0.00%)	0
1332Nissui Corporation	0.00 (0.00%)	0
132AIN Holdings Co Ltd	0.00 (0.00%)	0
131ACCN Group Corp	0.00 (0.00%)	0
130AVeritas In Silico Inc	0.00 (0.00%)	0